January 21, 2016 – Patients are now being enrolled in a new study to assess the effectiveness and safety of inferior vena cava (IVC) filters — small medical devices implanted in the body to stop blood clots from reaching the heart or lungs. The five-year-long study will involve 2,100 patients at 60 medical sites around the country. PRESERVE (Predicting the Safety and Effectiveness of...
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.
3141 Hood Street, Suite 700
Dallas, Texas 75219
Contact Us 800.226.9880
